A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD

Summary

It is estimated that in the United States there are approximately 8 million individuals with moderate to severe chronic kidney disease (CKD), not on dialysis. Volume expansion plays an important role in the pathogenesis of hypertension in patients with CKD. For this pilot study, the investigators hypothesize that administration of chlorthalidone among patients with moderate to severe CKD will improve blood pressure (BP).

Timeline

Start

2012-08

Primary completion

2013-08

Completion

2013-08

Drugs

Indications